China National Accord Medicines Corporation Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 56,585.86 million compared to CNY 54,616.77 million a year ago. Revenue was CNY 56,585.86 million compared to CNY 54,616.77 million a year ago.

Net income was CNY 1,189.66 million compared to CNY 1,047.64 million a year ago. Basic earnings per share from continuing operations was CNY 2.14 compared to CNY 1.88 a year ago. Diluted earnings per share from continuing operations was CNY 2.14 compared to CNY 1.88 a year ago.